BRÈVE

sur MediClin AG (isin : DE0006595101)

MEDICLIN Increases 2024 Full-Year Financial Projections

MEDICLIN Aktiengesellschaft, based in Offenburg, has announced an upward revision of its financial guidance for the 2024 fiscal year. Initially projecting a Group EBIT between EUR 33.0 and 39.0 million, the company now anticipates EBIT ranging from EUR 48.0 to 54.0 million. This adjustment reflects a significant improvement in expected financial performance.

The sales forecast has also been adjusted. Originally set between a decrease of 2.0% and no growth, it now predicts an increase between 1.0% and 3.0%. These revised figures suggest a more optimistic outlook compared to previous estimations. Preliminary figures for both the fourth quarter and the overall 2024 financial year are scheduled for release on 27 February 2025.

R. P.

Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de MediClin AG